Neil John Glassford

Neil John Glassford

Auto-generated profile, based on publicly available information

Neil John Glassford

Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
RBRinaldo Bellomo
Rinaldo Bellomo
JKJohn A. Kellum
John A. Kellum
CRClaudio Ronco
Claudio Ronco
RWRon Wald
Ron Wald
JMJohan Martensson
Johan Martensson
ASAntoine Schneider
Antoine Schneider

27 February 2013 in Intensive Care Medicine
Verified
Journal Article
Closed access
ASAntoine G. Schneider
Antoine G. Schneider
RBRinaldo Bellomo
Rinaldo Bellomo
SBSean M. Bagshaw
Sean M. Bagshaw
NGNeil J. Glassford
Neil J. Glassford
SLSerigne Lo
Serigne Lo
MGMartin Gallagher
Martin Gallagher

18 December 2014 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
NYNOR'AZIM MOHD BIN MOHD YUNOS
NOR'AZIM MOHD BIN MOHD YUNOS
RBRinaldo Bellomo
Rinaldo Bellomo
NGNeil Glassford
Neil Glassford
HSHarvey Sutcliffe
Harvey Sutcliffe
QLQue Lam
Que Lam
MBMichael Bailey
Michael Bailey

1 October 2013 in Journal of Critical Care
Verified
Journal Article
Closed access
SSSatoshi Suzuki
Satoshi Suzuki
GEGlenn M. Eastwood
Glenn M. Eastwood
LPLeah Peck
Leah Peck
NGNeil J. Glassford
Neil J. Glassford
RBRinaldo Bellomo
Rinaldo Bellomo

27 December 2014 in Critical Care
Verified
Journal Article
Open access
PDF file
NGNeil J Glassford
Neil J Glassford
GEGlenn M Eastwood
Glenn M Eastwood
RBRinaldo Bellomo
Rinaldo Bellomo
Fluid bolus therapy (FBT) is a standard of care in the management of the septic, hypotensive, tachycardic and/or oliguric patient. However, contemporary evidence for FBT improving patient-centred outcomes is scant. Moreover, its physiological effects in contemporary ICU environments and populations are poorly understood. Using three electronic databases, we identified all studies describing FBT between January 2010 and December 2013. We found 33 studies describing 41 boluses. No randomised controlled trials compared FBT with alternative interventions, such as vasopressors. The median fluid bolus was 500 ml (range 100 to 1,000 ml) administered over 30 minutes (range 10 to 60 minutes) and the most commonly administered fluid was 0.9% sodium chloride solution. In 19 studies, a predetermined physiological trigger initiated FBT. Although 17 studies describe the temporal course of physiological changes after FBT in 31 patient groups, only three studies describe the physiological changes at 60 minutes, and only one study beyond this point. No studies related the physiological changes after FBT with clinically relevant outcomes. There is a clear need for at least obtaining randomised controlled evidence for the physiological effects of FBT in patients with severe sepsis and septic shock beyond the period immediately after its administration.‘Just as water retains no shape, so in warfare there are no constant conditions’Sun Tzu (‘The Art of War’)

1 June 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
SSSatoshi Suzuki
Satoshi Suzuki
GEGlenn M. Eastwood
Glenn M. Eastwood
NGNeil J. Glassford
Neil J. Glassford
LPLeah Peck
Leah Peck
HYHelen Young
Helen Young
RBRinaldo Bellomo
Rinaldo Bellomo
To assess the feasibility and safety of a conservative approach to oxygen therapy in mechanically ventilated ICU patients. Pilot prospective before-and-after study. A 22-bed multidisciplinary ICU of a tertiary care hospital in Australia. A total of 105 adult (18 years old or older) patients required mechanical ventilation for more than 48 hours: 51 patients during the "conventional" before period and 54 after a change to "conservative" oxygen therapy. Implementation of a conservative approach to oxygen therapy (target SpO2 of 90-92%). We collected 3,169 datasets on 799 mechanical ventilation days. During conservative oxygen therapy the median time-weighted average SpO2 on mechanical ventilation was 95.5% (interquartile range, 94.0-97.3) versus 98.4% (97.3-99.1) (p < 0.001) during conventional therapy. The median PaO2 was 83 torr (71-94) versus 107 torr (94-131) (p < 0.001) with a change to a median FIO2 of 0.27 (0.24-0.30) versus 0.40 (0.35-0.44) (p < 0.001). Conservative oxygen therapy decreased the median total amount of oxygen delivered during mechanical ventilation by about two thirds (15,580 L [8,263-29,351 L] vs 5,122 L [1,837-10,499 L]; p < 0.001). The evolution of the PaO2/FIO2 ratio was similar during the two periods, and there were no difference in any other biochemical or clinical outcomes. Conservative oxygen therapy in mechanically ventilated ICU patients was feasible and free of adverse biochemical, physiological, or clinical outcomes while allowing a marked decrease in excess oxygen exposure. Our study supports the safety and feasibility of future pilot randomized controlled trials of conventional compared with conservative oxygen therapy.